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The low-fat “diet–heart hypothesis” has been controversial for nearly 100 years. The
low-fat–high-carbohydrate diet, promulgated vigorously by the National Cholesterol Edu-
cation Program, National Institutes of Health, and American Heart Association since the
Lipid Research Clinics-Primary Prevention Program in 1984, and earlier by the U.S.
Department of Agriculture food pyramid, may well have played an unintended role in the
current epidemics of obesity, lipid abnormalities, type II diabetes, and metabolic syndromes.
This diet can no longer be defended by appeal to the authority of prestigious medical
organizations or by rejecting clinical experience and a growing medical literature suggesting
that the much-maligned low-carbohydrate–high-protein diet may have a salutary effect on
the epidemics in question. (J Am Coll Cardiol 2004;43:731–3) © 2004 by the American
College of Cardiology Foundationt
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rI am bound by my own definition of criticism: A
disinterested endeavor to learn and propagate the best
that is that is known and thought in the world.
—Mathew Arnold, 1861
he role of diet in the genesis of atherosclerosis has been
tudied extensively for nearly a century, since Anitschkow
nduced fatty deposits in rabbit aortas by feeding cholesterol
nd saturated fats to rabbits. Although today the relation-
hip between elevated serum cholesterol (SC) and coronary
rtery disease (CAD) is well established, the role of diet in
oth the prevention and treatment of CAD remains unset-
led and highly controversial. Mann wrote in 1977: “A
eneration of research on the diet–heart hypothesis has
nded in disarray” (1). E. H. Ahrens, Jr., one of the
riginators of the diet–heart hypothesis, said in 1985 that it
as not yet proven that dietary modification could prevent
AD (2). Studies, including comparative population-based
ietary investigations, by Ancel Keys in the 1950s, focused
n dietary saturated fats (3). In the 1960s, Senator George
cGovern’s bipartisan Senate committee and the U.S.
epartment of Agriculture (USDA) gave further impetus to
he low-fat diet–heart hypothesis (4).
See page 725
Subsequent promotion of the low-fat diet, which came to
ominate current nutritional thought, began in earnest with
he National Institutes of Health (NIH)-sponsored Lipid
esearch Clinics Coronary Primary Prevention Trial
LRC-CPPT) (5). In this study, cholestyramine, given over
ome seven years, reduced SC by about 10% and mortality
y a widely publicized relative 24%. Although statistically
ignificant, the absolute reduction was far less impressive:
% in the placebo and 1.6% in the treated cohort. In spite
f much skepticism regarding the clinical significance of this
esult, the LRC-CPPT investigators concluded correctly
From the Dayton Heart Hospital, Dayton, Ohio.
Manuscript received September 23, 2003; revised manuscript received October 6,(003, accepted October 14, 2003.hat the lowering of SC was pivotal in the prevention and
anagement of CAD. This decision was validated when
tatin trials reduced cholesterol by 30% to 35% and pro-
uced unassailable evidence of improved CAD end points,
lthough it is increasingly recognized that some of the
enefit from statins may reside in non-lipid mechanisms.
Another inference drawn from the LCR-CPPT proved
o be less fortuitous. Even though the LCR-CPPT was a
rug and not a diet trial, the LRC-CPPT investigators—
he NIH, the National Cholesterol Education Program
NCEP), and the American Heart Association (AHA)—
ade a leap of faith: if lowering SC by medication was
ffective against CAD, reducing dietary fat intake would
lso lower SC and produce a similar result.
There followed what became perhaps one of America’s
ost extensive public relations campaigns: convincing the
rofession as well as the public that avoiding dietary fat was
key element in the prevention and treatment of athero-
clerotic CAD. The NIH, NCEP, AHA, USDA, and a
ost of medical organizations were joined by the food
ndustry in publicizing and promoting this concept. One
ad only to walk through any supermarket to find a plethora
f cookies, cakes, ice cream, and nearly every imaginable
ood product prominently marked “low-fat.” The message,
erhaps unintended, was unmistakable: eat all the low-fat
oods you want; they are safe. Yet many of these low-fat
oods were high in carbohydrates (Carb) and prepared with
aturated and trans-fatty acids (6).
The medical literature contained warnings largely ignored
y the profession and related organizations. Rosenman (7), in
n extensive review, found that SC is not strongly related to or
rimarily regulated by diet. He also cited widespread discor-
ant beliefs about a causal role of diet in CAD. Hu et al. (8)
rote that replacing saturated and trans-unsaturated fats with
nhydrogenated mono-unsaturated and poly-unsaturated fats
as more effective in preventing CAD in women than in
educing overall fat intake. They noted that low-fat–high-
arbohydrate (LF-HCarb) diets were widely recommended to
educe the risk of CAD by reducing low-density lipoprotein
LDL) by limiting dietary fat. However, because of its high-
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The Diet–Heart Hypothesis: A Critique March 3, 2004:731–3arb content, LF-HCarb diets also decrease high-density
ipoprotein (HDL) and increase triglycerides, well-established
ndependent risk factors for coronary disease (8).
Yancey et al. (9) noted: “Information about the best diet
to prevent CAD) is incomplete, unscientific and often
onflicting.” These authors also contend that a low-fat diet
romulgated without limitation of Carb intake would in
eality become a high-Carb diet (9). The current epidemic
f obesity, type II diabetes, and the metabolic syndrome in
etrospect seems to be, in part, the inevitable result of the
F-HCarb diet, absent warnings against unlimited Carb
ntake. Yet these unfortunate nutritional approaches were
romoted aggressively by the profession and by the most
redible medical organizations and institutions, in concert
ith the USDA and the food industry.
In this milieu, obese Americans, frustrated by the failure
f traditional medical dietary advice, sought weight loss
hrough popular and highly publicized “Atkins” low-
arbohydrate–high-protein (LCarb-HP) diets. These diets
ere rejected and criticized by mainstream medicine be-
ause of potential risks from increased protein and fat
ontent. An AHA science advisory warned that LCarb-HP
iets might cause metabolically induced kidney and liver
amage and CAD (10). Thus far, however, there is little
vidence to substantiate these warnings, and there is evi-
ence that saturated fats, which represent the smallest
roportion of calories by the USDA food pyramid, may
arry little more risk than Carb, the class of food represent-
ng the bulk of USDA caloric recommendations (9).
In the current issue of the Journal, Kappagoda et al. (11)
iscuss the LCarb-HP diet and challenge its role in clinical
ardiology. They report the wide media coverage that
rticles on the LCarb-HP diet received during the last
HA meeting and emphasize theoretical, but as yet un-
roven, dangers that LCarb-HP diets may pose. They tend
o dismiss recent, somewhat promising LCarb-HP diet
esearch. For example, they give short shrift to a study
resented by Westman, Yancey, and Guyton at the 2002
HA scientific sessions, which found that LCarb-HP diets
educed weight, SC, LDL, very-low-density lipoprotein,
Abbreviations and Acronyms
AHA  American Heart Association
CAD  coronary artery disease
Carb  carbohydrate
HDL  high-density lipoprotein
LCarb-HP  low-carbohydrate–high-protein
LCR-CPPT  Lipid Research Clinics–Primary
Prevention Trial
LDL  low-density lipoprotein
LF-HCarb  low-fat–high-carbohydrate
NCEP  National Cholesterol Education Program
NIH  National Institutes of Health
SC  serum cholesterol
USDA  U.S. Department of Agriculturend percent of small LDL particles, suggesting possible wsefulness in treating the metabolic syndrome (12). Kappa-
oda et al. (11) also minimize the findings of other recent
tudies of 6- to 12-month duration (13–15) that show no ill
ffects of LCarb-HP diets but rather a tendency toward
reater weight loss, improved lipid patterns, and increased
nsulin sensitivity when compared with LF-HCarb diets.
appagoda et al. (11) conclude that a LCarb-HP diet
annot be recommended, because of potential nutritional
eficiencies and the absence of long-term data on efficacy
nd safety and because they “run counter to all current
vidence-based dietary recommendations.” They refer to the
F-HCarb diet as having an established record of “safety
nd efficacy,” a position difficult to sustain without ignoring
vidence supporting its culpability in the current epidemic
f obesity, type II diabetes, and the metabolic syndrome.
In a systemic review of dietary fat in preventing CAD,
ooper et al. (16) point out: “Despite decades of effort, and
any thousands of people randomized, there is still only
imited and inconclusive evidence of the effects of modifi-
ation of total, saturated, mono-unsaturated or poly-
aturated fats on cardiovascular morbidity and mortality”
16). The Hooper et al. study (16) included 27 trials, with
0,902 patient-years of observation, and reported a reduc-
ion of 9% in cardiovascular mortality and 16% in cardio-
ascular events, with little effect on total mortality. Some
riticized Hooper for underestimating the importance of
hese date from his own study. He responded: “Over 50
ears of endeavor, dietary fat trials have managed only 30
housand patient-years of observation in studies of at least 6
onths duration and only 8,300 person-years in trials
onger than 2 years in which usable data on mortality are
vailable. Much more data is available already for statins—
he 4S trials alone amassed over 19,000 person-years of
bservation, a mean of over 4 years for each . . . given the
aucity of data available, we feel it is remarkable that an
ffect was seen at all.” The Hooper review and the response
o it illustrate the difficulty of arriving at consensus on the
iet–heart hypothesis.
A clinical debate published in the New England Journal of
edicine further demonstrated the intensity of the diet–
eart hypothesis controversy (17). Connor and Connor
efended the LF-HCarb diet, pointing out USDA data that
howed that energy intake from dietary fat decreased from
0% to 33%, whereas Carb intake increased from 45% to
2% from the 1960s to 1995. Between 1970 and 1995,
nnual refined sugar consumption rose from 120 pounds to
50 pounds per capita. Although the Connors did lament
he plethora of fat-free foods that led to increased sugar
ntake in cookies, sweet rolls, frozen yogurt, and the like,
hey wrote that there was little doubt that Americans had
mproved their health by lowering their intake of dietary fat.
n that debate, Katan, Grundy, and Willet questioned
hether reduction in dietary fat intake would provide the
ealth benefits claimed by the Connors. Katan et al. (17)
ere concerned by the growing public perception that Carb
as innocuous and warned that LF-HCarb diets, while
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March 3, 2004:731–3 The Diet–Heart Hypothesis: A Critiqueeducing LDL, also lowered HDL and elevated triglycer-
des, which were independent CAD risk factors. They noted
hat, although dietary fat consumption had decreased since
976, obesity in the U.S. had increased by one-third.
Subsequently, Hu et al. (18) reported that obesity was the
ingle most important element in the occurrence of type II
iabetes and that the public was generally not aware of the
elationship between obesity and diabetes. They advocated
iets emphasizing unsaturated fats and high-fiber cereals
nd a low content of saturated fat, trans-fatty acids, and
oods with a high glycemic index. The latter include refined
tarches and sugars, which tend to cause a hyper-insulin
tate and promote type II diabetes. Trans-fatty acids are
elieved to be particularly unfavorable and are found in
ydrogenated oils, margarines, and commercially baked
ow-fat products and fast foods.
There is growing literature exploring the nature and
fficacy of the LCarb-HP diet. Westman et al. (12) found
hat the LCarb-HP diet led to sustained weight loss during
six-month trial. Serum cholesterol was decreased by
1 mg/dl, LDL by 10 mg/dl, and triglycerides by 56 mg/dl,
hile HDL increased by 8 mg/dl. There were no adverse
ffects (13). Bravada et al. (19) systematically reviewed 107
tudies with 3,168 participants in order to determine the
fficacy and safety of the LCarb-HP diet. There was wide
isparity in the duration and design of these studies, which
omplicated the analyses. These authors concluded that
here was inadequate evidence to make recommendations
or or against the LCarb-HP diet, particularly among
articipants older than age 50 (19). Samaha et al. (14)
ssigned 132 severely obese patients with a mean body mass
ndex of 43 and a 30% prevalence of diabetes or the
etabolic syndrome to either LF-HCarb or LCarb-HP
iets. Seventy-nine subjects completed the six-month study.
hose receiving the LCarb-HP diet lost more weight than
id the LF-HCarb group, with relative improvement in
nsulin sensitivity and triglyceride levels, even after adjust-
ent for weight loss. Insulin sensitivity was measured only
n subjects without diabetes and improved more among the
Carb-HP group. Weight loss and assignment to the
Carb-HP diet were independent predictors of improve-
ent in triglyceride levels and insulin sensitivity (14). Foster
t al. (15) reported a one-year multi-center randomized trial
omparing LCarb-HP and LF-HCarb diets in obese sub-
ects. The LCarb-HP group had a greater decrease in serum
riglycerides and increase in HDL than those receiving the
F-HCarb diet. Although this may have been due partly to
he greater weight loss with the LCarb-HP diet, the
hanges were larger than expected from weight loss alone.
here were no significant differences between the two
roups in blood pressure, LDL, and insulin sensitivity (15).
he authors of both these studies were conservative in
resenting their results. They did not dwell on modest
mprovement in some risk factors, such as increased insulin
ensitivity, reduction in weight, reduction in triglycerides,
nd in one study, elevation of HDL. Rather, in objectivend scientific fashion, they called for larger studies of longer
uration comparing LCarb-HP and LF-HCarb diets with
egard to cardiovascular outcomes and safety.
A balanced appraisal of the diet–heart hypothesis must
ecognize the unintended and unanticipated role that the
F-HCarb diet may well have played in the current epidemic
f obesity, abnormal lipid patterns, type II diabetes, and the
etabolic syndrome. Defense of the LF-HCarb diet, because
t conforms to current traditional dietary recommendations, by
ppealing to the authority of its prestigious medical and
nstitutional sponsors or by ignoring an increasingly critical
edical literature, is no longer tenable. The categoric rejection
f experience and an increasingly favorable medical literature,
hough still not conclusive, which suggests that the much-
aligned LCarb-HP diet may have a favorable impact on
besity, lipid patterns, type II diabetes, and the metabolic
yndrome, is also no longer tenable.
eprint requests and correspondence: Dr. Sylvan Lee Wein-
erg, Director of Medical Education, The Dayton Heart Hospital,
555 Southern Blvd., Dayton, Ohio 45429. E-mail: slwjal@
ol.com.
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